Cognition Therapeutics, Inc. (CGTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 80.08M |
| Enterprise Value | 51.39M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.27 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.01 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.62 |
| 52-Week Change 3 | 23.60% |
| S&P500 52-Week Change 3 | 25.77% |
| 52 Week High 3 | 3.4900 |
| 52 Week Low 3 | 0.9000 |
| 50-Day Moving Average 3 | 1.9304 |
| 200-Day Moving Average 3 | 1.6814 |
Share Statistics
| Avg Vol (3 month) 3 | 200.57k |
| Avg Vol (10 day) 3 | 81.6k |
| Shares Outstanding 5 | 40.04M |
| Implied Shares Outstanding 6 | 40.01M |
| Float 8 | 32.92M |
| % Held by Insiders 1 | 6.31% |
| % Held by Institutions 1 | 33.58% |
| Shares Short (Apr 15, 2024) 4 | 220.34k |
| Short Ratio (Apr 15, 2024) 4 | 1.4 |
| Short % of Float (Apr 15, 2024) 4 | 0.79% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.57% |
| Shares Short (prior month Mar 15, 2024) 4 | 228.13k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -74.08% |
| Return on Equity (ttm) | -79.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -50.63M |
| Net Income Avi to Common (ttm) | -25.79M |
| Diluted EPS (ttm) | -0.8600 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.92M |
| Total Cash Per Share (mrq) | 0.77 |
| Total Debt (mrq) | 1.24M |
| Total Debt/Equity (mrq) | 5.06% |
| Current Ratio (mrq) | 3.37 |
| Book Value Per Share (mrq) | 0.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16.02M |
| Levered Free Cash Flow (ttm) | -23.04M |
© 2024 Yahoo. All rights reserved.